ATE142268T1 - Retroviraler vektor - Google Patents

Retroviraler vektor

Info

Publication number
ATE142268T1
ATE142268T1 AT89906574T AT89906574T ATE142268T1 AT E142268 T1 ATE142268 T1 AT E142268T1 AT 89906574 T AT89906574 T AT 89906574T AT 89906574 T AT89906574 T AT 89906574T AT E142268 T1 ATE142268 T1 AT E142268T1
Authority
AT
Austria
Prior art keywords
transcription unit
introducing
sequence
retroviral vector
dna encoding
Prior art date
Application number
AT89906574T
Other languages
English (en)
Inventor
Eli Gilboa
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22726179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE142268(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE142268T1 publication Critical patent/ATE142268T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89906574T 1988-05-17 1989-05-17 Retroviraler vektor ATE142268T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19662888A 1988-05-17 1988-05-17

Publications (1)

Publication Number Publication Date
ATE142268T1 true ATE142268T1 (de) 1996-09-15

Family

ID=22726179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906574T ATE142268T1 (de) 1988-05-17 1989-05-17 Retroviraler vektor

Country Status (8)

Country Link
EP (1) EP0371119B1 (de)
JP (1) JPH02504344A (de)
AT (1) ATE142268T1 (de)
AU (1) AU631554B2 (de)
CA (1) CA1335798C (de)
DE (1) DE68927089T2 (de)
DK (1) DK13290A (de)
WO (1) WO1989011539A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
GB8901778D0 (en) * 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US6251675B1 (en) 1989-05-25 2001-06-26 Duke University Methods utilizing mutant rev genes encoding transdominant repressors of HIV replication
US5871958A (en) * 1989-05-25 1999-02-16 Duke University Mutant rev genes encoding transdominant repressors of HIV replication
GB2269175A (en) * 1992-07-31 1994-02-02 Imperial College Retroviral vectors
DE69333930T8 (de) * 1993-01-22 2007-02-22 The Regents Of The University Of Colorado, Boulder Lokalisierung von therapeutischen mitteln
FR2707091B1 (fr) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
AU7477394A (en) * 1993-07-30 1995-03-27 University Of Medicine And Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
US5902880A (en) * 1994-08-19 1999-05-11 Ribozyme Pharmaceuticals, Inc. RNA polymerase III-based expression of therapeutic RNAs
US6146886A (en) * 1994-08-19 2000-11-14 Ribozyme Pharmaceuticals, Inc. RNA polymerase III-based expression of therapeutic RNAs
CA2198210C (en) 1994-09-02 2006-07-11 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
FR2727429B1 (fr) 1994-11-30 1997-11-28 Haguenauer Odile Cohen Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs
JP3908274B2 (ja) 1995-03-09 2007-04-25 ゲーエスエフ−フォルシュンクスツェントラム・フュア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 遺伝子治療用の抗菌ペプチドをコードする治療用遺伝子を有するベクター
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
RU2185821C2 (ru) 1996-03-27 2002-07-27 Бавариан Нордик Рисерч Инститьют А/С Трансдуцирующие цитохром р450 ретровирусные векторы
EP1045922B1 (de) 1998-01-06 2004-09-29 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression

Also Published As

Publication number Publication date
DK13290A (da) 1990-03-16
EP0371119B1 (de) 1996-09-04
CA1335798C (en) 1995-06-06
AU631554B2 (en) 1992-12-03
AU3740489A (en) 1989-12-12
DE68927089D1 (de) 1996-10-10
EP0371119A1 (de) 1990-06-06
JPH02504344A (ja) 1990-12-13
DK13290D0 (da) 1990-01-16
WO1989011539A1 (en) 1989-11-30
DE68927089T2 (de) 1997-04-03
EP0371119A4 (en) 1990-12-05

Similar Documents

Publication Publication Date Title
DE68927089D1 (de) Retroviraler vektor
ATE317908T1 (de) Verfahren zur herstellung von rekombinanten viren
GB2243611A (en) Use of viral enzymes
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
DE69300750D1 (de) Verfahren zur Herstellung von Hohlfasermembranbund.
FI881025A0 (fi) Kemisk process med ett funktionellt steg som aer kaensligt foer en komponent i den inmatade stroemmen.
BR8704419A (pt) Cartucho de gas co2 pressurizado e processo de preparacao domestica de bebidas carbonatadas
DE3688575D1 (de) Gemilderte reduktionsreaktion zur herstellung von arylhydroxylaminen.
NO20003400L (no) Borevæske med invertert emulsjon, inneholdende blandinger av sekundære estere fremstilt ved omdannelse av olefiner, og fremgangsmÕte for fremstilling av slike blandinger
ATE240924T1 (de) Verfahren zur herstellung von methylmercatopropanal
DE3873342D1 (de) Nicht-zylindrischer reaktor zur herstellung von furnace-russ.
NO166394C (no) Fremgangsmaate for oksydering i gassfase, samt reaktor foranvendelse ved fremgangsmaaten.
DE3784237D1 (de) Partiell oxydation von kohlenwasserstoffgasen.
NO873809L (no) Skip med en i skipets akterstevn anordnet propell, samt fremgangsmaate ved skipets drift.
ES2021031B3 (es) Compuesto de dioxazina que tiene un grupo reactivo tipo fibra de vinilsulfona.
IT7924478A0 (it) Processo per l'epossidazione catalitica di olefine con acqua ossigenata.
EP0256135A4 (de) Gaslaser mit hochfrequenzerregung.
Gilad et al. Measurement of the 16O (pi+, pi 0p) reaction
DE69313832D1 (de) Verfahren zur Herstellung von 2,4-Dihydroxydiphenylsulfon
ATE133709T1 (de) Peroxidase-gen von mikrobischem ursprung
DE68922507D1 (de) Verfahren zur Herstellung von beta-2',2'-Difluornukleosiden.
NO883566D0 (no) Forsterkningselement ved fartoeyer for offshorearbeider.
NO874574L (no) Fremgangsmaate for fremstilling av styrenert hydrokinon.
DE3770086D1 (de) Verfahren zur herstellung von 2,2-bis(4'-hydroxyphenyl)-propanen.
ATE53001T1 (de) Verfahren zur herstellung von optisch aktiven hydrochinonderivaten, sowie von d-alphatocopherol.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee